Moderna, Inc. (MRNA)
Largest Insider Buys in Sector
MRNA Stock Price History Chart
MRNA Stock Performance
About Moderna, Inc.
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, human immunodeficiency virus, herpes simplex virus, and varicella-zoster virus …
Insider Activity of Moderna, Inc.
Over the last 12 months, insiders at Moderna, Inc. have bought $0 and sold $89.85M worth of Moderna, Inc. stock.
On average, over the past 5 years, insiders at Moderna, Inc. have bought $999,989 and sold $724.58M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 52,631 shares for transaction amount of $999,989 was made by SAGAN PAUL (director) on 2020‑02‑14.
List of Insider Buy and Sell Transactions, Moderna, Inc.
| 2024-12-09 | Sale | Chief Legal Officer | 529 0.0001% | $44.68 | $23,637 | -8.37% | ||
| 2024-12-03 | Sale | President | 314 <0.0001% | $43.30 | $13,595 | -1.74% | ||
| 2024-12-03 | Sale | Chief Legal Officer | 112 <0.0001% | $43.30 | $4,849 | -1.74% | ||
| 2024-11-29 | Sale | President | 291 <0.0001% | $42.79 | $12,452 | -1.11% | ||
| 2024-11-29 | Sale | Chief Legal Officer | 1,418 0.0004% | $42.79 | $60,675 | -1.11% | ||
| 2024-11-29 | Sale | Chief Financial Officer | 1,420 0.0004% | $42.79 | $60,761 | -1.11% | ||
| 2024-11-11 | Sale | President | 277 <0.0001% | $46.10 | $12,771 | -1.88% | ||
| 2024-10-07 | Sale | Chief Financial Officer | 715 0.0003% | $60.12 | $42,986 | -24.32% | ||
| 2024-09-09 | Sale | Chief Legal Officer | 551 0.0002% | $73.57 | $40,539 | -30.11% | ||
| 2024-09-03 | Sale | President | 318 0.0001% | $76.99 | $24,483 | -25.83% | ||
| 2024-09-03 | Sale | Chief Legal Officer | 114 <0.0001% | $76.99 | $8,777 | -25.83% | ||
| 2024-08-29 | Sale | President | 300 0.0001% | $78.03 | $23,408 | -29.94% | ||
| 2024-08-29 | Sale | Chief Legal Officer | 162 <0.0001% | $78.03 | $12,640 | -29.94% | ||
| 2024-08-29 | Sale | Chief Financial Officer | 162 <0.0001% | $78.03 | $12,640 | -29.94% | ||
| 2024-08-28 | Sale | Chief Legal Officer | 1,319 0.0006% | $79.39 | $104,722 | -30.46% | ||
| 2024-08-28 | Sale | Chief Financial Officer | 1,321 0.0006% | $79.39 | $104,881 | -30.46% | ||
| 2024-08-12 | Sale | President | 254 0.0001% | $84.10 | $21,363 | -29.79% | ||
| 2024-07-31 | Sale | director | 15,000 0.0109% | $119.96 | $1.8M | -51.07% | ||
| 2024-07-24 | Sale | director | 15,000 0.0107% | $117.80 | $1.77M | -50.20% | ||
| 2024-07-17 | Sale | director | 15,000 0.0111% | $122.84 | $1.84M | -49.93% |
Insider Historical Profitability
| Trieu Vuong | Chairman of the Board | 11117141 2.8889% | $39.39 | 2 | 0 | |
| Ramelli Joseph W. | Chief Executive Officer | 440653 0.1145% | $39.39 | 4 | 0 | |
| SAGAN PAUL | director | 14951 0.0039% | $39.39 | 1 | 1 | +262.16% |
| FRENCH J MICHAEL | CEO | 10000 0.0026% | $39.39 | 1 | 0 |